Legend Biotech
The Executive Director, Global Program Leader at Legend Biotech will oversee the end‑to‑end development and execution of in vivo CAR‑T programs, aligning scientific, clinical, regulatory, manufacturing, and commercial strategies. Reporting to the President of R&D, the role provides senior strategic leadership, governance, and cross‑functional coordination to advance these advanced cell therapy assets through IND, clinical proof‑of‑concept, and lifecycle management.
Headquarters
Somerset, New Jersey, United States
Company Size
1001-5000 employees
Founded
2014
Legend Biotech is a global, commercial-stage biotechnology company developing and manufacturing novel therapies. We explore and apply innovative technologies to deliver cutting-edge options for patients around the world.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Legend Biotech.
97% above the average for this role
Principal Scientist, Engineered Cell Therapy Discovery
Bristol Myers Squibb
Senior Scientist, In vivo Immunology – Targeted LNP Delivery
Tr1X
CAR T-Cell Engineering Scientist
Integrated Resources INC
Director, Immunology Cell Therapy Discovery
AstraZeneca
Scientist, II
AbbVie
Director, WW Autoimmune Cell Therapy Medical Affairs
Bristol Myers Squibb